Related Experiment Video
Updated: May 30, 2026
07:46
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
Genetic variability in SNCA and Parkinson's disease
Lasse Pihlstrøm1, Mathias Toft
1Department of Neurology, Oslo University Hospital, Rikshospitalet, P.O. Box 4950, Nydalen, 0424 Oslo, Norway. lasse.pihlstrom@ous-hf.no
Neurogenetics
|July 30, 2011
Summary
Genetic insights into Parkinson's disease highlight the role of the SNCA gene and alpha-synuclein protein. Future research needs to identify specific genetic variants contributing to Parkinson's disease risk.
Area of Science:
- Neurogenetics
- Molecular Neurology
Background:
- Parkinson's disease (PD) pathogenesis research has advanced significantly due to genetic discoveries.
- The SNCA gene, encoding alpha-synuclein, is central to PD, identified in monogenic forms and linked to sporadic PD risk.
- Alpha-synuclein is a key pathogenic protein and a major component of Lewy bodies in Parkinson's disease.
Purpose of the Study:
- To review the current understanding of SNCA genetic variability in Parkinson's disease.
- To emphasize the challenge of characterizing functionally relevant susceptibility alleles.
- To propose strategies for identifying causative variants in PD.
Main Methods:
- Review of existing literature on SNCA genetics and Parkinson's disease.
- Analysis of association studies linking SNCA variants to PD risk.
- Discussion of future research directions, including targeted resequencing.
Main Results:
- SNCA is the first gene identified in monogenic Parkinson's disease.
- Common SNCA variants are associated with the risk of sporadic Parkinson's disease.
- The precise functional variants conferring risk remain to be fully characterized.
Conclusions:
- Understanding SNCA variability is crucial for elucidating Parkinson's disease pathogenesis.
- Identifying specific susceptibility alleles requires novel strategies beyond current association studies.
- Targeted resequencing is a promising approach for pinpointing causal SNCA variants in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...